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Introduction
As patients with idiopathic inflammatory myopathies (IIM) may benefit from immune therapies it is crucial to develop diagnostic tools that achieve a high level of sensitivity and specificity. Sets of diagnostic criteria for different types of IIM, based on a combination of clinical and pathological findings, have been proposed for use in clinical trials and research studies [1, 2] . However, muscle biopsy is still the definitive diagnostic procedure in clinical practice and should ideally be performed before starting treatment [3] . A major concern is that as the pathology is often patchy the biopsy may not show an inflammatory infiltrate although it may be present in other parts of the muscle. This is a well-known pitfall, especially when the biopsy is performed after treatment has been initiated [4] . In addition, inflammatory infiltrates are nonspecific and may also occur in other myopathies such as dysferlinopathy, facioscapulohumeral dystrophy and other types of muscular dystrophy and myasthenia gravis, and may lead to a mistaken diagnosis of an IIM [5, 6] . Other markers of an autoimmune process are therefore necessary to improve the sensitivity and specificity of the muscle biopsy. Vascular membrane attack complex (MAC) and immunoglobulin deposition, and upregulation of major histocompatibility complex (MHC) antigens have been proposed as diagnostic criteria for IIM [2] . A number of previous studies, which have been summarised in Tables 1 and 2 , have reported positive immunohistochemical staining for MHC in IIM and other muscle conditions. Some studies have also addressed the diagnostic value of MHC expression with different methodologies and results [7] [8] [9] .
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MHC-I is expressed but is undetectable immunohistochemically in normal muscle
fibres and is up-regulated in IIM. MHC-I molecules are necessary for antigen-specific T cell-mediated cytotoxicity and can mediate a response against surface antigens on myofibres [10] . Previous studies have also shown that MHC-I can behave as a pathogenic molecule in its own right since its expression can precede lymphocytic cell infiltration, and transgenic mice overexpressing MHC-I have been shown to develop a severe myopathy even in the absence of inflammation [11] [12] [13] [14] . Unlike the inflammatory infiltrates, MHC-I expression is still detectable even after short-term immunosuppressive treatment and in patients with chronic myositis [9, 15] . Moreover, MHC-I staining often occurs early, preceding the inflammatory infiltrates, and is present diffusely throughout the biopsy and is thus less likely to be affected by sampling error [16] . Nevertheless, even though it has been considered helpful in distinguishing IIM from other muscle diseases, it is not specific and also occurs in other myopathies [17] . On the other hand, MHC-II expression does not occur constitutively on normal mature muscle fibres, unlike myoblasts in culture which express MHC-II and can behave as antigen-presenting cells [18, 19] . Few studies have addressed the diagnostic value of MHC-II expression in IIM and the results of previous studies have varied (Table 1 and 2) .
In the present study we analysed the sensitivity and specificity of immunohistochemical staining for MHC-I and MHC-II in the diagnosis of IIM in a large group of muscle biopsies from a single reference centre. We paid particular attention to the contribution of MHC-II staining in improving diagnostic accuracy, as, in our experience, positive MHC-I staining alone is nonspecific. [2] . In the case of IBM all patients fulfilled the clinical and histopathologic criteria for definite IBM according to Griggs et al [20] and the 2011 proposed ENMC criteria for clinicopathologically defined IBM [21] .
The NIM group included: muscular dystrophies and distal myopathies 37; non-immune mediated necrotising myopathies 36; metabolic myopathies 20; non-specific myopathies 93; neurogenic disorders 46; other muscle disorders 14. Details of the cases of necrotising myopathy, muscular dystrophies and distal myopathies are given
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in Table 3 . The mean (±sd) ages were 59.1±16.1 years in the IIM and 51.9±21.5 years in NIM group. Further details of the age ranges of the different subgroups are provided in Table 4 .
Immunohistochemistry techniques
Needle or open muscle biopsies were mainly from the vastus lateralis, deltoid or gastrocnemius muscles. The muscle tissue was routinely frozen in isopentane cooled with liquid nitrogen and stored at -70°C. Routine staining techniques included haematoxylin and eosin (H&E), modified Gomori trichrome and enzyme histochemistry for mitochondria (NADH, SDH and cytochrome c oxidase). Immunoperoxidase stains for MHC-I and II and C5b-9 (membrane attack complex of complement) and CD31 were performed on 8-µm acetone fixed cryostat sections using the streptavidin-biotin complex technique with diaminobenzidine as a colour indicator. Immunostaining for Tand B-cell subsets was performed on paraffin sections using the streptavidin-biotin complex technique. For MHC-I, the antibody used was a monoclonal mouse anti- 
Interpretation of biopsies
All biopsies were reported by an experienced myopathologist (VF or RCJ), who was not blinded, and were reviewed by an independent observer (FLM) if there was any uncertainty about the diagnosis. Inter-observer variability in reporting was not formally evaluated. Biopsies were classified as showing definitely positive or negative staining, while biopsies with questionable or faint staining were considered as being negative. Positive staining in necrotic or regenerating muscle fibres was not taken into account in the classification of biopsies. The patterns and distribution of sarcolemmal and sarcoplasmic staining in non-necrotic muscle fibres were interpreted qualitatively.
Staining was classified as being 'focal' if it was present in single fibres or small groups of fibres only and 'widespread' if it was present in most or all the fibres in the biopsy.
In addition, sarcolemmal staining was classified as being 'complete' or 'incomplete', depending on whether it involved the entire surface of muscle fibres or was patchy in Table 5 . MHC-I showed a very high sensitivity (0.984) and low specificity (0.071), while MHC-II showed a high specificity (0.908) and moderate sensitivity (0.605). The ROC curves for the IIM group are shown in Figure 5 .
When only MHC-I staining was taken into consideration, the area under the curve was 0.53 (standard error, SE: 0.28; p=0.215). The area increased to 0.762 (SE: 0.024; p<0.001) when MHC-II staining was added. In the absence of MHC-I staining, the ROC curve for MHC-II staining showed a similar area (0.754, SE: 0.025; p<0.001).
Correlation with presence of inflammatory infiltrates
Mononuclear inflammatory infiltrates were present in 147 biopsies (79.9%) in the IIM group and 43 biopsies (17.3%) in the NIM group (Table 6 ). In the IIM group there was
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no association between MHC-I positivity and the presence of an inflammatory infiltrate (chi-square, χ²=0.591, p=0.446), whereas there was a significant association between MHC-II positivity and infiltrates (chi-square, χ²=6.041, p=0.014). In the NIM group there was no association between either MHC-I (Fisher's exact test, p=0.374) or MHC-II (chi-square, χ ²=3.255, p=0.071) positivity and the presence of inflammatory infiltrates.
Patterns of MHC-I and MHC-II staining
The patterns of staining in the IIM and NIM groups are summarised in Tables 7 & 8 .
Both focal and widespread patterns of sarcoplasmic and sarcolemmal MHC-I staining of non-necrotic fibres were found in both the IIM and NIM groups, but widespread staining was more frequent in the IIM group and focal staining was more frequent in the NIM group. In the case of MHC-II, both widespread and focal patterns of staining were found in the IIM group, while in the NIM group positive MHC-II staining was infrequent, being present in only a small proportion of cases, and sarcolemmal staining was more often focal. A Chi-square test for independence showed that the IIM group had a more widespread and complete pattern of sarcolemmal expression for MHC-I and MHC-II than the NIM group and more frequent widespread sarcoplasmic staining.
Correlation with disease duration and prior treatment
In the IIM group, disease duration from onset of symptoms to muscle biopsy ranged from 0 to 30 years (2.0 ± 4.1 years). At the time of biopsy 63 patients were on treatment with prednisolone (44), or a combination of prednisolone and methotrexate or azathioprine (19) . Logistic regression analysis showed that neither disease duration
Text 13
nor absence of prior treatment were predictors of MHC-I positivity (χ²=3.57, p=0.167) and MHC-II positivity (χ²= 5.75, p=0.056). There was also a lack of correlation between the presence of inflammatory infiltrates and disease duration and prior treatment (χ²=4.060, p=0.131).
Discussion
The diagnosis of IIM has in the past been based largely on the criteria established by Bohan and Peter [22] . New diagnostic criteria have since been proposed [1, 2, 23, 24] but muscle biopsy remains the most sensitive and specific diagnostic tool, as well as the most common cause of misdiagnosis due to misinterpretation [25] . The inclusion of immunohistochemical staining for MHC-I has been recommended for cases of suspected IIM to increase the degree of diagnostic certainty [2, 23] . A number of previous studies have demonstrated a high sensitivity of up-regulated MHC-I expression in IIM biopsies, but relatively few studies have investigated the specificity of MHC-I staining compared to large numbers of control NIM biopsies, or have provided sufficient data to define the role of staining for MHC-II. In this study of the largest groups of IIM and NIM biopsies to date, we investigated the sensitivity and specificity of positive MHC-I and MHC-II staining and their combined value in distinguishing IIM from NIM biopsies. Our findings confirm that positive MHC-I staining has a high sensitivity in IIM, but indicate that its specificity for IIM is very low unless it is combined with positive MHC-II staining.
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Expression of MHC-I in muscle fibres is associated with antigen processing and presentation and plays an integral part in the pathogenesis of the CD8+ T-cell mediated inflammatory myopathies PM and IBM [26] . However, recent studies have shown that MHC-I overexpression can also mediate muscle fibre damage and dysfunction even in the absence of inflammation, through non-immune mechanisms such as endoplasmic reticulum (ER) stress and induction of the unfolded protein response [11, 26, 27] . This could explain the incomplete efficacy of immunosuppressive drugs in the treatment of IIM and the disparity between the severity of muscle damage and extent of inflammatory infiltrates in muscle biopsies, as well as the increased MHC-I expression in non-inflammatory myopathies. The demonstration of MHC-I upregulation and its co-localisation with the ER marker calnexin in myositis biopsies has confirmed that MHC molecules can play a critical role in mediating ER stress by disrupting ER homeostasis [12, 28] . Endoplasmic reticulum stress has also been associated with other conditions besides IIM such as myotonic dystrophy, dysferlinopathy, myasthenia gravis, statin-induced myopathy and metabolic myopathies [17, [29] [30] [31] [32] . It seems that ER stress mechanisms can activate inflammatory responses through a number of different pathways and mediators: e.g. NF-кB, JNK, reactive oxygen species, interleukin-6 and TNF-α [33, 34] . Recent studies also suggest that immature muscle precursor cells are a possible source of type I interferon secretion and may be implicated in HLA class I overexpression through the activation of Toll-like Receptor 3 [35] .
The finding of upregulation of MHC-I expression in both the IIM and NIM groups may indicate that this is a secondary non-specific and common response to muscle damage Text 15 from various causes. However, our findings do not shed any light on whether the increased MHC-I expression may contribute to the muscle fibre injury per se in these conditions or is purely a downstream consequence of ER stress. The variable frequency and patterns of MHC-I immunostaining in IIM reported in the literature could be related to methodological differences, in particular variation in antibody dilution (Table 1) , and in methods of detection and amplification. Such differences may account for our finding of a higher frequency of MHC-I staining in the NIM group than in previous studies. The use of a more sensitive (low dilution) protocol could result in more widespread MHC-I staining, whereas with higher antibody dilutions, more restricted patchy or perifascicular patterns of staining might be found. A comparison of positive staining rates and staining patterns achieved in different centres using high and low antibody dilutions would be helpful in the standardisation of protocols for MHC immunohistochemical staining. Ultimately, an internationally accepted diagnostic standard based upon a level of sensitivity in terms of false negatives and false positives (for a defined level of strong MHC-I staining) for selected disease groups restricted not only to known IIMs and normal controls but also non-IIM disease controls is necessary to ensure that a "positive" result has equivalent diagnostic significance across multiple centres.
In this study, we found a high specificity (0.891) and moderate sensitivity (0.605) for MHC-II expression in IIM and, as shown in Figure 5 found positive expression with varying sensitivities (25%-93%) or specificity (100%) in IIM [7, 36] . MHC-II expression is necessary to activate T-helper cells and to initiate an immune response, and muscle cells can act as facultative antigen-presenting cells through the expression of MHC-II molecules [19, 37] . Their ability to process and present endogenous antigens via MHC-II molecules is believed to influence the perpetuation or spreading of muscle immune responses through a T-cell stimulatory function [38] . This was shown in sporadic IBM, where β-amyloid targeted for lysosomal degradation via autophagy was associated with MHC-II overexpression. The independence of MHC expression in muscle fibres from the presence of adjacent inflammatory cell infiltrates has also been noted in previous studies [15, [44] [45] [46] [47] . This was observed in both the early and late chronic phases of the disease, and in symptomatic and asymptomatic muscles from the same individuals [48, 49] . However, in the present study we found that, unlike MHC-I, there was a significant association between MHC-II expression and the presence of inflammatory infiltrates in the IIM group. It is also well known that there is a poor correlation between clinical symptoms and the presence of inflammatory infiltrates in patients with myositis [15, 43, 50] Text 17 although clearance of infiltrates may correlate with clinical improvement after commencement of corticosteroid therapy [47] . The expression of cytokines such as IL-1α has also been shown to be independent of inflammatory infiltrates or the state of evolution of the disease [15, 49] . In addition, we found that the frequency of MHC expression was not affected by disease duration or prior treatment. A previous study also found that MHC overexpression was independent of disease duration and the degree of muscle damage, [51] while two other studies found that MHC-I expression was independent of corticosteroid therapy administered prior to the muscle biopsy and was not affected by the short-term use of immunosuppressive agents [9, 52] .
In conclusion, our findings provide further evidence that MHC-I expression is nonspecific and appears to be a common response to muscle damage resulting from both Footnote: S-IBM (sporadic inclusion body myositis); DM (dermatomyositis); PM (polymyositis); IMNM (immune-mediated necrotising myopathies); NIMNM (non-immune mediated necrotising myopathies). The 'Other myopathies' group included two cases of myofibrillar myopathy, which showed patchy low level MHC-I staining, but negative MHC-II staining. References 39 Table 7 : Patterns of MHC-I and MHC-II staining in the idiopathic inflammatory myopathies (IIM) and non-inflammatory myopathies (NIM) groups.
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Footnote: Percentages indicate the proportions of cases with a particular staining pattern. Staining was classified as 'focal' if only single fibres or small groups of fibres were positively stained and 'widespread' if staining was present in most or all the fibres in the biopsy. Sarcolemmal staining was classified as being 'complete' or 'incomplete', depending on whether it involved the entire surface of muscle fibres or was patchy in distribution. Differences between the IIM and NIM groups were tested using the chi-square test for independence. 
